Regeneron Pharmaceuticals Company Profile (NASDAQ:REGN)

Analyst Ratings

Consensus Ratings for Regeneron Pharmaceuticals (NASDAQ:REGN) (?)
Ratings Breakdown: 1 Sell Rating(s), 12 Hold Rating(s), 13 Buy Rating(s)
Consensus Rating:Hold (Score: 2.46)
Consensus Price Target: $505.04 (29.05% upside)

Analysts' Ratings History for Regeneron Pharmaceuticals (NASDAQ:REGN)
Show:
DateFirmActionRatingPrice TargetActions
7/19/2016Leerink SwannReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/12/2016BTIG ResearchReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/30/2016Sanford C. BernsteinReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/23/2016Citigroup Inc.Reiterated RatingBuy$470.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/17/2016Canaccord GenuityReiterated RatingHold$450.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/8/2016Chardan CapitalDowngradeSell$325.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/8/2016Wells Fargo & Co.Reiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/6/2016Piper Jaffray Cos.Reiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/6/2016Cowen and CompanyReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/16/2016Robert W. BairdReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/19/2016Jefferies GroupReiterated RatingHold$444.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/12/2016Brean CapitalReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/8/2016Morgan StanleyLower Price Target$436.00 -> $415.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/2/2016Roth CapitalReiterated RatingBuy$555.00 -> $520.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/1/2016Credit Suisse Group AGReiterated RatingHold$481.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/18/2016Goldman Sachs Group Inc.Reiterated RatingBuy$506.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/17/2016SunTrust Banks Inc.Lower Price TargetNeutral$450.00 -> $410.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/15/2016GabelliInitiated CoverageBuy$574.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/13/2016JPMorgan Chase & Co.Reiterated RatingNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/11/2016Bank of America Corp.Reiterated RatingBuy$649.00 -> $525.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/10/2016Royal Bank Of CanadaReiterated RatingOutperform$676.00 -> $668.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/10/2016Barclays PLCLower Price TargetEqual Weight$610.00 -> $425.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/31/2015Raymond James Financial Inc.Initiated CoverageOutperform$615.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/6/2015ArgusBoost Price TargetBuy$560.00 -> $660.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/4/2015Deutsche Bank AGReiterated RatingBuy$650.00 -> $720.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/27/2015BMO Capital MarketsReiterated RatingMarket Perform$381.00 -> $494.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/22/2015Northland SecuritiesInitiated CoverageMarket Perform$560.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/2/2014GuggenheimInitiated CoverageBuy$432.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/23/2014 forward)

Earnings

Earnings History for Regeneron Pharmaceuticals (NASDAQ:REGN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/2/2016        
5/5/2016Q116$2.58$2.57$1.18 billion$1.20 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/9/2016Q415$3.40$2.83$1.17 billion$1.10 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/4/2015Q315$2.62$3.47$1.05 billion$1.14 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/4/2015Q215$2.77$2.89$887.03 million$999.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2015Q115$2.50$2.88$820.30 million$870.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/10/2015Q414$2.78$2.79$775.42 million$802.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/4/2014Q314$2.57$2.52$733.04 million$726.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/5/2014Q214$2.30$2.47$647.99 million$666.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/8/2014Q114$0.94$0.58$609.04 million$626.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/11/2014Q413$0.97$2.24$579.17 million$610.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2013Q313$0.92$2.40$501.93 million$597.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2013Q2 2013$0.92$1.73$470.63 million$458.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/3/2013Q1 2013$1.46$1.78$424.26 million$440.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/14/2013Q4 2012$1.11$1.47$392.64 million$415.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/24/2012$1.14$1.89ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/25/2012$0.45$0.90ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/26/2012($0.33)$0.37ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/13/2012($0.60)($0.37)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/28/2011($0.40)($0.69)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Regeneron Pharmaceuticals (NASDAQ:REGN)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162$1.47$2.49$1.98
Q2 20161$1.62$1.62$1.62
Q3 20161$1.69$1.69$1.69
Q4 20162$1.77$2.79$2.28
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Regeneron Pharmaceuticals (NASDAQ:REGN)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Regeneron Pharmaceuticals (NASDAQ:REGN)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/14/2016SanofiMajor ShareholderBuy64,731$363.86$23,553,021.66View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/24/2016Arthur F RyanDirectorSell1,000$396.64$396,640.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/18/2016Plew Daniel P VanEVPSell4,413$385.77$1,702,403.01View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/6/2016Joseph L GoldsteinDirectorSell2,000$425.00$850,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/21/2016Joseph L GoldsteinDirectorSell2,000$375.00$750,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/17/2016SanofiMajor ShareholderBuy161,157$392.46$63,247,676.22View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/12/2016SanofiMajor ShareholderBuy83,938$465.04$39,034,527.52View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/29/2015Douglas S. MccorkleVPSell3,954$552.08$2,182,924.32View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/10/2015Michael S. BrownDirectorSell3,000$546.45$1,639,350.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/2/2015George YancopoulosinsiderSell43,348$549.03$23,799,352.44View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/18/2015P Roy VagelosChairmanSell17,240$587.90$10,135,396.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/10/2015Plew Daniel P. VanSVPSell5,123$554.85$2,842,496.55View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/9/2015Neil StahlEVPSell42,101$561.45$23,637,606.45View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/3/2015P Roy VagelosChairmanSell17,242$580.19$10,003,635.98View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/2/2015George YancopoulosinsiderSell43,348$571.61$24,778,150.28View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/6/2015SanofiMajor ShareholderBuy80,538$459.71$37,024,123.98View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/23/2015SanofiMajor ShareholderBuy147,209$534.67$78,708,236.03View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/21/2015Michael S. BrownDirectorSell3,000$551.55$1,654,650.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/17/2015Charles A. BakerDirectorSell5,000$550.00$2,750,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/14/2015Peter PowchikSVPSell23,485$573.38$13,465,829.30View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/15/2015Joseph L GoldsteinDirectorSell2,000$550.00$1,100,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/22/2015Joseph L GoldsteinDirectorSell2,000$526.85$1,053,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/27/2015Robert Alexander IngramDirectorSell1,379$513.39$707,964.81View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/26/2015Plew Daniel P VanSVPSell18,370$508.42$9,339,675.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/22/2015Douglas S MccorkleVPSell13,000$515.60$6,702,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/22/2015Joseph L GoldsteinDirectorSell4,000$514.28$2,057,120.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/15/2015Michael S BrownDirectorSell5,000$495.00$2,475,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/25/2015Charles A BakerDirectorSell5,000$454.96$2,274,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/24/2015Michael S AbermanSVPSell4,843$478.99$2,319,748.57View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/18/2015Michael S AbermanSVPSell3,442$465.00$1,600,530.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/17/2015Robert J TerifaySVPSell10,993$451.01$4,957,952.93View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/16/2015Joseph J LarosaSVPSell18,311$450.00$8,239,950.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/27/2015Douglas S MccorkleVPSell3,000$416.24$1,248,720.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/26/2015Marc Tessier-LavigneDirectorSell3,000$421.95$1,265,850.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/24/2015Robert J TerifaySVPSell11,173$423.67$4,733,664.91View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/23/2015Plew Daniel P VanSVPSell9,431$427.82$4,034,770.42View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/20/2015Joseph L GoldsteinDirectorSell5,000$423.65$2,118,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/17/2015Michael S AbermanSVPSell3,692$404.46$1,493,266.32View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/2/2015Leonard S SchleiferCEOSell1,500$410.58$615,870.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/2/2015Peter PowchikSVPSell10,822$414.08$4,481,173.76View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/24/2014SanofiMajor ShareholderBuy201,459$393.21$79,215,693.39View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/16/2014Douglas S MccorkleVPSell8,486$410.15$3,480,532.90View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/24/2014Alfred G GilmanDirectorSell40,000$408.44$16,337,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/24/2014Neil StahlSVPSell5,307$412.93$2,191,419.51View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/18/2014Robert J TerifaySVPSell22,362$405.79$9,074,275.98View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/13/2014Plew Daniel P VanSVPSell8,575$399.34$3,424,340.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/12/2014Joseph L GoldsteinDirectorSell5,000$398.31$1,991,550.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/12/2014Leonard S SchleiferCEOSell45,817$400.30$18,340,545.10View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/28/2014Leonard S SchleiferCEOSell69,112$404.01$27,921,939.12View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/24/2014Michael S BrownDirectorSell5,000$399.00$1,995,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/24/2014Murray A GoldbergSVPSell26,788$400.70$10,733,951.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/16/2014SanofiMajor ShareholderBuy31,717$349.26$11,077,479.42View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/15/2014SanofiMajor ShareholderBuy140,632$345.15$48,539,134.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/10/2014P Roy VagelosChairmanSell10,328$350.07$3,615,522.96View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/27/2014Joseph L GoldsteinDirectorSell2,000$350.31$700,620.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/19/2014Michael S AbermanVPSell3,611$350.00$1,263,850.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/18/2014Douglas S MccorkleVPSell5,875$353.00$2,073,875.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/15/2014Michael S BrownDirectorSell3,000$349.20$1,047,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/14/2014Joseph L GoldsteinDirectorSell2,000$347.65$695,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/13/2014P Roy VagelosChairmanSell8,028$340.01$2,729,600.28View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/11/2014Neil StahlSVPSell11,646$339.96$3,959,174.16View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/11/2014P Roy VagelosChairmanSell11,972$340.11$4,071,796.92View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/8/2014Neil StahlSVPSell2,841$340.60$967,644.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/7/2014Plew Daniel P VanSVPSell6,806$338.37$2,302,946.22View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/6/2014Joseph L GoldsteinDirectorSell2,000$331.20$662,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/15/2014SanofiMajor ShareholderBuy129,100$314.92$40,656,172.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/14/2014SanofiMajor ShareholderBuy300,000$316.80$95,040,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/10/2014SanofiMajor ShareholderBuy175,000$311.08$54,439,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/9/2014SanofiMajor ShareholderBuy348,000$309.76$107,796,480.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/7/2014SanofiMajor ShareholderBuy356,700$312.37$111,422,379.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/2/2014SanofiMajor ShareholderBuy212,400$307.25$65,259,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2014SanofiMajor ShareholderBuy212,400$300.20$63,762,480.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/30/2014SanofiMajor ShareholderBuy262,400$281.17$73,779,008.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/23/2014Plew Daniel VanSVPSell5,369$295.93$1,588,848.17View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/19/2014Sanofimajor shareholderBuy190,751$300.04$57,232,930.04View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/28/2014Sanofimajor shareholderBuy306,945$306.73$94,149,239.85View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/27/2014Sanofimajor shareholderBuy306,945$311.01$95,462,964.45View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/24/2014Charles BakerDirectorSell15,000$302.67$4,540,050.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/24/2014Sanofimajor shareholderBuy306,945$307.91$94,511,434.95View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/21/2014Sanofimajor shareholderBuy305,115$321.22$98,009,040.30View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/20/2014Sanofimajor shareholderBuy67,703$328.33$22,228,925.99View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/17/2014Michael BrownDirectorSell2,000$334.29$668,580.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/17/2014Sanofimajor shareholderBuy115,711$328.46$38,006,435.06View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/12/2014Sanofimajor shareholderBuy220,995$334.69$73,964,816.55View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/11/2014Sanofimajor shareholderBuy380,532$330.41$125,731,578.12View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/7/2014Sanofimajor shareholderBuy150,277$328.72$49,399,055.44View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/3/2014Sanofimajor shareholderBuy251,594$338.12$85,068,963.28View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/27/2014Michael BrownDirectorSell1,000$335.00$335,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/25/2014Joseph GoldsteinDirectorSell1,000$338.86$338,860.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/25/2014Murray GoldbergSVPSell11,871$339.55$4,030,798.05View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/21/2014Alfred GilmanDirectorSell5,000$340.00$1,700,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/21/2014Murray GoldbergSVPSell21,258$336.51$7,153,529.58View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/20/2014Joseph GoldsteinDirectorSell1,000$326.99$326,990.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/18/2014Michael AbermanVPSell3,648$331.42$1,209,020.16View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/18/2014Robert TerifaySVPSell12,865$332.68$4,279,928.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/13/2014Neil StahlSVPSell22,612$318.82$7,209,157.84View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/12/2014George YancopoulosInsiderSell88,987$320.33$28,505,205.71View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/12/2014Joseph GoldsteinDirectorSell1,000$320.62$320,620.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/11/2014Alfred GilmanDirectorSell5,000$320.00$1,600,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/11/2014Douglas MccorkleVPSell5,819$325.00$1,891,175.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/11/2014P Roy VagelosChairmanSell11,475$325.10$3,730,522.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/7/2014Sanofimajor shareholderBuy168,511$286.78$48,325,584.58View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/5/2014Sanofimajor shareholderBuy397,264$284.12$112,870,647.68View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/3/2014Sanofimajor shareholderBuy208,972$283.78$59,302,074.16View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/28/2014Sanofimajor shareholderBuy157,920$275.90$43,570,128.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/14/2014Alfred GilmanDirectorSell5,000$300.00$1,500,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/14/2014Douglas MccorkleVPSell4,000$290.00$1,160,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/2/2014Peter PowchikSVPSell20,668$274.77$5,678,946.36View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/20/2013Peter PowchikSVPSell9,133$270.21$2,467,827.93View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/26/2013George SingDirectorSell10,000$295.00$2,950,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/6/2013Joseph GoldsteinDirectorSell1,000$300.74$300,740.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/19/2013Leonard SchleiferCEOSell102,949$302.67$31,159,573.83View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/19/2013P Roy VagelosChairmanSell145,356$302.86$44,022,518.16View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/18/2013Plew Daniel VanSVPSell23,977$303.17$7,269,107.09View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/18/2013William RobertsVPSell15,000$304.00$4,560,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/9/2013Leonard S SchleiferCEOSell5,000$275.47$1,377,350.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/23/2013Joseph GoldsteinDirectorSell1,000$238.29$238,290.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/10/2013Charles A BakerDirectorSell15,000$251.84$3,777,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/31/2013Arthur F RyanDirectorSell2,500$249.55$623,875.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/28/2013Joseph L GoldsteinDirectorSell4,000$252.20$1,008,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/21/2013Murray A GoldbergCFOSell66,835$259.74$17,359,722.90View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/17/2013Michael S BrownDirectorSell15,000$275.19$4,127,850.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/14/2013Michael S AbermanVPSell5,529$279.61$1,545,963.69View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/13/2013Neil StahlSVPSell23,038$276.88$6,378,761.44View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/10/2013George L SingDirectorSell5,000$270.00$1,350,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/8/2013Robert J TerifaySVPSell8,231$261.23$2,150,184.13View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/6/2013P Roy VagelosChairmanSell12,018$263.15$3,162,536.70View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/27/2012P Roy VagelosChairmanSell64,753$175.22$11,346,020.66View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/26/2012Charles A BakerDirectorSell15,000$173.87$2,608,050.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/14/2012Michael S BrownDirectorSell7,000$147.03$1,029,210.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/1/2012Arthur F RyanDirectorSell10,000$145.57$1,455,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/6/2012Charles A BakerDirectorSell15,000$150.00$2,250,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/23/2012George L SingDirectorSell10,000$140.50$1,405,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Regeneron Pharmaceuticals (NASDAQ:REGN)
DateHeadline
07/22/16 05:53 PMAre Analysts Still Saying "Buy" this Stock: Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - TGP
07/22/16 05:53 PMFriday Session Wrap-up for Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - Engelwood Daily
07/22/16 09:02 AMToday's Top Gainers in the Market Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) from Healthcare - The Daily Leicester
07/21/16 06:26 PMRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN): Sell-Side Ratings and Company Earnings Glance - Engelwood Daily
07/21/16 06:26 PMHigh Expectations Remain For Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - TGP
07/21/16 06:26 PMRegeneron Pharmaceuticals Inc (NASDAQ:REGN) Stock Technicals at Critical Inflection Point - CML News
07/21/16 06:26 PMMarket Minute - Focus on Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock - TGP
07/21/16 02:56 PMAnalysts Gauge Alexion Pharmaceuticals’ Return Potential -
07/21/16 08:58 AMJapan is Breathing Life into the Stem Cell Space, Astelles & Pluristem Are Benefiting
07/20/16 06:58 PMIs Regeneron Pharmaceuticals, Inc.(NASDAQ: REGN), a large market cap stock a smart buy? - The Daily Leicester
07/20/16 12:46 PMWhy I Bought Shares of Regeneron Pharmaceuticals Inc. Last Week - Regeneron Pharmaceuticals is packed with potential, and it's on sale -- so this Fool decided to take advantage.
07/20/16 08:55 AMOption Market: Regeneron Pharmaceuticals Inc Risk Hits A Lowered Level - CML News
07/20/16 08:55 AMStock Strength in Focus for Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - Press Telegraph
07/19/16 06:13 PMLong Term Value Play: Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - TGP
07/19/16 06:13 PMShares Lower on the Year Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - Press Telegraph
07/19/16 06:13 PMIs it Finally Safe to Buy Regeneron Pharmaceuticals Inc (NASDAQ:REGN)? - Street Report
07/19/16 07:04 AMMovers to Watch: Edwards Lifesciences Corp (NYSE:EW), Regeneron Pharmaceuticals Inc (NASDAQ:REGN) - Post Registrar
07/19/16 07:04 AMAnalysts Pounding the Table on Shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - TGP
07/19/16 06:21 AM3 Biotech Stocks to Buy and Hold -
07/18/16 03:15 PMRegeneron Pharmaceuticals, Inc. – Value Analysis (NASDAQ:REGN) : July 18, 2016 -
07/18/16 11:36 AMRegeneron Pharmaceuticals : Announces Upcoming 2016 Investor Conference Presentation
07/18/16 08:30 AMRegeneron Announces Upcoming 2016 Investor Conference Presentation - [PR Newswire] - TARRYTOWN, N.Y., July 18, 2016 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast a management presentation at the following investor conference: 36 th Annual Canaccord Genuity ...
07/17/16 05:30 PMShare Performance Summary for: Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - Press Telegraph
07/15/16 05:05 PMMoving Stock in Focus: Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - Press Telegraph
07/15/16 05:05 PMUpdate on Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) for the day - Twin County News
07/15/16 05:05 PMRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Current Analyst Ratings - Fiscal Standard
07/14/16 09:43 AMRegeneron Pharmaceuticals Becomes #41 Most Shorted Nasdaq 100 Component, Replacing Vertex Pharmaceuticals
07/14/16 09:43 AMRegeneron Pharmaceuticals : Announces 2016 Winners of the Prize for Creative Innovation
07/14/16 09:43 AMStock Update (NASDAQ:REGN): Regeneron Announces 2016 Winners of the Regeneron Prize for Creative Innovation
07/13/16 06:29 PMRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Earnings Concentration and Analyst Target Watch - Engelwood Daily
07/13/16 04:02 PMHere's Why Regeneron Pharmaceuticals, Inc. Dropped Another 12% in June - Continuing concerns over Praluent weigh on Regeneron, but shareholders would be wise to look at the whole picture.
07/13/16 09:01 AMCompany Update: Regeneron Pharmaceuticals
07/13/16 08:05 AMRegeneron’s Dupilumab: How Much Potential Does It Hold? -
07/13/16 07:30 AMRegeneron Announces 2016 Winners of the Regeneron Prize for Creative Innovation - [PR Newswire] - TARRYTOWN, New York, July 13, 2016 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the winners of the fourth annual Regeneron Prize for Creative Innovation, an award designed to acknowledge, reward and foster talented early-career biomedical scientists. This year, Regeneron awarded $155,000 in prize money to 10 awardees and two institutions. "These talented postdoctoral and graduate student winners have shown significant dedication and promise early in their scientific careers, and we are confident they have what it takes to be future leaders in biomedicine," said George D. Yancopoulos, M.D., Ph.D., President of Regeneron Laboratories and Chief Scientific Officer of Regeneron.
07/12/16 08:06 PMRegeneron’s Robust Pipeline -
07/12/16 10:28 AMShares now down at $375.74 (REGN) Award-Winning Chef Elizabeth Falkner…
07/12/16 09:20 AMAmgen's Repatha Gains FDA Approval for New Dosing Option -
07/12/16 08:27 AMInstant Analysis: Amgen's Latest Approval Raises the Bar Yet Again on Regeneron Pharmaceuticals Inc and Sanofi SA (ADR) -
07/12/16 08:08 AMWhat’s Driving Regeneron’s Premium Valuation? -
07/12/16 06:00 AMAward-Winning Chef Elizabeth Falkner Reveals Her Struggle with Atopic Dermatitis to Highlight the Physical and Psychological Impact of the Disease - [PR Newswire] - TARRYTOWN, N.Y. and CAMBRIDGE, Mass., July 12, 2016 /PRNewswire/ -- Celebrity chef, restaurateur, and media personality Elizabeth Falkner has teamed up with Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), Sanofi Genzyme, the National Eczema Association, and the Dermatology Nurses Association to launch Understand AD, a national awareness campaign focused on educating people about moderate-to-severe atopic dermatitis (AD), a potentially serious chronic inflammatory skin disease. Falkner is speaking out for the first time about her own struggle with the disease to drive awareness about the physical impact and effects on quality of life for people living with atopic dermatitis, and to encourage others to speak up about their experience.
07/11/16 11:06 AMWhat’s behind Regeneron’s Operating Efficiency? -
07/11/16 10:44 AMStock Performance Rundown on: Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - Press Telegraph
07/11/16 08:07 AMIs It Slower Growth for Regeneron’s Eylea in 2016 and 2017? -
07/11/16 07:03 AMRegeneron Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : REGN-US : July 11, 2016 -
07/09/16 09:11 AMLarge Cap Biotechnology: Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - Twin County News
07/08/16 08:25 PMInside Alnylam Pharmaceuticals’s Analyst Recommendations in 2016 -
07/08/16 06:04 PMActive Stock Tracker: Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - Press Telegraph
07/08/16 06:04 PMNews Sentiment and Impact Score Review for :Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) - Press Telegraph
07/08/16 06:04 PMRegeneron Pharmaceuticals, Inc. (NASDAQ:REGN) – Top Stock from Healthcare Sector - The Daily Leicester
07/08/16 02:03 PMRegeneron in 2Q16: How Much Revenue Growth Could It Have? -

Social

About Regeneron Pharmaceuticals

Regeneron Pharmaceuticals logoRegeneron Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, invents, develops, manufactures and commercializes medicines for the treatment of serious medical conditions. The Company's segment includes activities related to the discovery, development and commercialization of pharmaceutical products for the treatment of serious medical conditions. It commercializes medicines for eye diseases, high low-density lipoprotein (LDL) cholesterol and a rare inflammatory condition, and has product candidates in development in other areas of unmet medical need, including oncology, rheumatoid arthritis (RA), asthma, atopic dermatitis, pain and infectious diseases. Its marketed products include EYLEA (aflibercept) injection, Praluent (alirocumab) Injection and ARCALYST (rilonacept) injection for subcutaneous use. Its other products include Sarilumab (REGN88), Dupilumab (REGN668), REGN2222, Fasinumab (REGN475), REGN2810, REGN2176-3, Evinacumab (REGN1500) and REGN1908-1909.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: REGN
  • CUSIP: 75886F10
Key Metrics:
  • Previous Close: $389.52
  • 50 Day Moving Average: $368.27
  • 200 Day Moving Average: $394.82
  • P/E Ratio: 62.05
  • P/E Growth: 1.89
  • Market Cap: $40.81B
  • Beta: 1.06
  • Current Year EPS Consensus Estimate: $6.6 EPS
  • Next Year EPS Consensus Estimate: $8.41 EPS
Additional Links:
Regeneron Pharmaceuticals (NASDAQ:REGN) Chart for Saturday, July, 23, 2016